GeneDx Holdings Corp. (WGS) Operating Margin
- Operating margin · 12 months: Value -20.34%; Formula and calculation Operating income / revenue. Period ending 2026-06-30..
Operating margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | -20.34% | Operating income / revenue. Period ending 2026-06-30. $-92.41M ÷ $454.43M × 100 ≈ -20.34% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | -92.41M USD | Operating Income (Loss) |
| Revenue | 454.43M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | 139.18M USD | Cost of Goods and Services Sold |
| Research and development | 83.83M USD | Research and Development Expense |
| Selling, general and administration | (m) | Selling, General and Administrative Expense |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-30 | $-92.41M | $454.43M | $139.18M | $83.83M | (m) | -20.34% |
| 2026-03-31 | $-66.00M | $442.68M | $134.77M | $79.25M | (m) | -14.91% |
| 2025-12-31 | $-13.08M | $427.54M | $129.37M | $72.03M | (m) | -3.06% |
| 2025-09-30 | $9.96M | $402.19M | $122.08M | $59.07M | (m) | 2.48% |
| 2025-06-30 | $5.43M | $362.32M | $118.91M | $50.91M | (m) | 1.50% |
| 2025-03-31 | $-14.10M | $330.14M | $114.68M | $46.73M | (m) | -4.27% |
| 2024-12-31 | $-23.21M | $305.45M | $111.05M | $45.72M | (m) | -7.60% |
| 2024-09-30 | $-57.66M | $267.23M | $108.28M | $46.38M | (m) | -21.58% |
| 2024-06-30 | $-92.85M | $243.66M | $107.28M | $49.01M | (m) | -38.11% |
| 2024-03-31 | $-133.89M | $221.85M | $109.67M | $55.24M | (m) | -60.35% |
| 2023-12-31 | $-180.60M | $202.57M | $112.56M | $58.27M | (m) | -89.15% |
| 2023-09-30 | $-479.83M | $206.50M | $163.57M | $70.38M | (m) | -232.37% |
| 2023-06-30 | $-527.68M | $236.43M | $205.21M | $69.45M | (m) | -223.19% |
| 2023-03-31 | $-638.71M | $223.89M | $241.03M | $79.48M | (m) | -285.28% |
| 2022-12-31 | $-667.65M | $234.69M | $261.44M | $86.20M | (m) | -284.48% |
| 2022-09-30 | $-458.55M | $231.15M | $244.38M | $84.08M | (m) | -198.38% |
| 2022-06-30 | $-456.00M | $191.09M | $226.18M | $88.56M | (m) | -238.63% |
| 2022-03-31 | $-338.80M | $201.94M | $208.59M | $73.34M | (m) | -167.78% |
| 2021-12-31 | $-446.15M | $212.19M | $228.80M | $105.16M | (m) | -210.25% |
| 2021-09-30 | $-92.87M | (m) | (m) | (m) | (m) | (m) |
| 2021-06-30 | $-3.33M | (m) | (m) | (m) | (m) | (m) |
| 2021-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-12-31 | $-30.41M | $196.17M | $113.39M | $34.91M | (m) | -15.50% |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |